STOCK TITAN

Haemonetics To Present At The Jefferies Plasma Summit

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, the President and CEO, will present at the Jefferies Plasma Summit on March 11, 2021, at 10:45 a.m. ET.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, the President and CEO, will present at the Jefferies Plasma Summit on March 11, 2021, at 10:45 a.m. ET. The presentation will be accessible live via webcast, with a replay available for one month. Haemonetics is focused on delivering innovative medical products and solutions, primarily in blood and plasma collection, surgical services, and hospital transfusions.

Loading...
Loading translation...
Argus Session date unavailable
-2.01% session move Open Argus
Details

News Market Reaction – HAE

The recorded move for HAE in the trading session of this news was -2.01%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BOSTON, Feb. 26, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Jefferies Plasma Summit on Thursday, March 11, 2021, at 10:45 a.m. ET.

The public may access Mr. Simon's video presentation live via webcast at: https://wsw.com/webcast/jeff171/hae/1665048. A replay of the video will be available for one month using the same link.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

 

Investor Contact:

Media Contact:

Olga Guyette, Director-Investor Relations

Carla Burigatto, Vice President-Communications

(781) 356-9763

(781) 348-7263

olga.guyette@haemonetics.com 

carla.burigatto@haemonetics.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-jefferies-plasma-summit-301236318.html

SOURCE Haemonetics Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Haemonetics present at the Jefferies Plasma Summit?

Haemonetics will present at the Jefferies Plasma Summit on March 11, 2021, at 10:45 a.m. ET.

Who is presenting for Haemonetics at the Jefferies Plasma Summit?

Chris Simon, the President and CEO of Haemonetics, will be presenting.

How can I watch Haemonetics' presentation at the Jefferies Plasma Summit?

The presentation can be accessed live via webcast at https://wsw.com/webcast/jeff171/hae/1665048.

Is there a replay available for Haemonetics' presentation?

Yes, a replay of the presentation will be available for one month after the event.

What is the focus of Haemonetics Corporation?

Haemonetics focuses on innovative medical products and solutions in blood and plasma component collection, surgical services, and hospital transfusion services.

Keep reading